跳至主要内容
临床试验/CTRI/2022/12/048454
CTRI/2022/12/048454招募中2 期

Randomized Controlled Trial of Vidangadi Guggul compare with Dhatri Nishe in Madhumeha with special reference to Type II Diabetes Mellitus.

Government Ayurved College and Hospital Nagpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who are willing to participate in trial and ready to give written
  • 2. Patients of type II DM of 30 to 70 years of age, irrespective of sex.
  • 3. Newly detected patients as well as the patient who are not responding to any
  • oral hypoglycemic agents and blood sugar level is as below of type II DM.
  • 4. Patients with fasting blood sugar ranges from 110-200 mg/dl and post prandial
  • blood sugar ranges from 180-250 mg/dl, with clinical signs and symptoms of
  • 5. Glycosylated hemoglobin (HbA1C) range 6.5 % - 10%.
  • 6. Patient who are diagnosed in routine check-up or present with
  • other complaints in the hospital.
  • 7. Patient who has not participated in any research project in last 6 months.
  • 8. Patient with controlled hypertension i.e., systolic blood pressure upto140
  • mm of Hg while diastolic blood pressure up to 100 mm of Hg.

排除标准

  • 1. Patients having fasting blood sugar level >200mg/dl and post meal
  • blood sugar level >250 mg/dl.
  • 2. Patients who are not willing to participate in trial and not ready to give
  • written consent.
  • 3. Patients having age below 30 and above 70 years.
  • 4. Pregnant women and lactating mothers.
  • 5. Acute complications of hyperglycemia like DKA (Diabetic Ketoacidosis).
  • 6. Type 1 DM, Gestational DM and patient on insulin therapy.
  • 7. Patients suffering from the serious macrovascular and microvascular
  • complications of DM.
  • 8. Patients suffering from any other serious systemic diseases.
  • 9. Diabetes Mellitus developed due to secondary causes such as infective pancreatitis,
  • autoimmune pathology etc.

研究者

发起方
Government Ayurved College and Hospital Nagpur

相似试验